EUVIMEDEUVIMED entdecken
Crossref

Single Amine or Guanidine Modification on Norvancomycin and Vancomycin to Overcome Multidrug-Resistance through Augmented Lipid II Binding and Increased Membrane Activity

Xiaolei Bian, Zhifu Chen, Fang Li, Yuanyuan Xie, Yi Li, Youhong Luo, Xiangman Zou, Hui Wang, Jingwen Zhang, Xiaowen Wang, Jinyong Zhang, Dongliang Guan iD

Journal of Medicinal Chemistry · 28.11.2024 · 67 (22) · 20639-20663

DOI: 10.1021/acs.jmedchem.4c02196 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 06.11.2024. Verfasst von Xiaolei Bian und 11 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong 264117, China. Hauptthemen laut MEDLINE: Vancomycin, Anti-Bacterial Agents, Microbial Sensitivity Tests, Uridine Diphosphate N-Acetylmuramic Acid. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Shanghai Municipal Human Resources and Social Security Bureau, Medical and Health Science and Technology Development Project of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vancomycin and norvancomycin have diminished antibacterial efficacy due to acquired or intrinsic resistance from mutations in the terminal dipeptide of lipid II in Gram-positive bacteria or failure to penetrate into the periplasm in Gram-negative bacteria. Herein, we rationally designed and synthesized a series of vancomycin analogues bearing single amine or guanidine functionality, altering various linkers and modification sites, to combat the resistance. Extensive antibacterial screening was performed to delineate a comprehensive SAR. Many derivatives revitalized the activity in vitro, exhibiting a 4-128-fold or 2-16-fold enhancement against the acquired or intrinsic resistance with lower toxicity. Significantly, the optimal compound 4g demonstrated greater pharmacokinetic and pharmacodynamic profiles. Further studies uncovered additional independent and synergistic mechanisms for 4g, including the enhanced membrane activity and augmented inhibition of peptidoglycan biosynthesis via increased lipid II binding, highlighting its potential as a future lead candidate to replenish the glycopeptide antibiotic arsenal.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VancomycinAnti-Bacterial AgentsMicrobial Sensitivity TestsUridine Diphosphate N-Acetylmuramic AcidGuanidineStructure-Activity RelationshipDrug Resistance, Multiple, BacterialAminesAnimalsCell MembraneHumansMice

Substanzen

VancomycinAnti-Bacterial AgentsUridine Diphosphate N-Acetylmuramic Acidmuramyl-NAc-(pentapeptide)pyrophosphoryl-undecaprenolGuanidineAmines

Autor:innen und Institutionen

  • Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong 264117, China.
  • National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical University, Chongqing 400038, China.
  • Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 555 Zuchongzhi Rd, Pudong, Shanghai 201203, China.
  • Department of Endocrinology and Metabolism, Clinical Research Center, Shandong Provincial Key Medical and Health Discipline of Endocrinology, Affiliated Hospital of Shandong Second Medical University, Weifang 261031, Ch…
  • Nanjing Cantech Microbial Technology Co. Ltd., No. 18, Zhilan Rd, Jiangning, Nanjing 211100, China.
  • University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China.

ORCID-Profile: Dongliang Guan

Förderung

  • China Postdoctoral Science Foundation
  • Shanghai Municipal Human Resources and Social Security Bureau
  • Medical and Health Science and Technology Development Project of Shandong Province
  • National Natural Science Foundation of China

Zitieren

APA

Bian, X., Chen, Z., Li, F., Xie, Y., Li, Y., Luo, Y., Zou, X., Wang, H., Zhang, J., Wang, X., Zhang, J., & Guan, D. (2024). Single Amine or Guanidine Modification on Norvancomycin and Vancomycin to Overcome Multidrug-Resistance through Augmented Lipid II Binding and Increased Membrane Activity. Journal of Medicinal Chemistry, 67(22), 20639-20663. https://doi.org/10.1021/acs.jmedchem.4c02196

Vancouver

Bian X, Chen Z, Li F, Xie Y, Li Y, Luo Y, et al. Single Amine or Guanidine Modification on Norvancomycin and Vancomycin to Overcome Multidrug-Resistance through Augmented Lipid II Binding and Increased Membrane Activity. Journal of Medicinal Chemistry. 2024;67(22):20639-20663. doi:10.1021/acs.jmedchem.4c02196

BibTeX
@article{Bian2024,
  author = {Bian, Xiaolei and Chen, Zhifu and Li, Fang and Xie, Yuanyuan and Li, Yi and Luo, Youhong and Zou, Xiangman and Wang, Hui and Zhang, Jingwen and Wang, Xiaowen and Zhang, Jinyong and Guan, Dongliang},
  title = {Single Amine or Guanidine Modification on Norvancomycin and Vancomycin to Overcome Multidrug-Resistance through Augmented Lipid II Binding and Increased Membrane Activity},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  volume = {67},
  number = {22},
  pages = {20639--20663},
  doi = {10.1021/acs.jmedchem.4c02196}
}
Kostenlos starten →